Oncology Clinical Researcher

Alignerr Corp.; Atlanta (GA); Remote; USD 83,000 - 131,000; Part time

Job summary

Alignerr is seeking an Oncology Clinical Researcher to shape how AI trains on cancer trial data. You will design trials, evaluate regulatory and scientific standards, and ensure AI insights meet real-world clinical needs.

The role is fully remote, hourly contract, with 10–40 hours per week, and offers the autonomy to manage projects on your schedule while collaborating with leading AI teams.

Qualifications

• Experience designing and managing oncology clinical trials.
• Familiarity with FDA/EMA submission standards.
• Ability to analyze trial data including endpoints and biomarkers.
• Experience evaluating AI outputs for regulatory alignment.

Responsibilities

• Design and evaluate oncology trial protocols, covering study design, enrollment frameworks, and regulatory compliance.
• Analyze cancer trial data for safety, efficacy, and data quality.
• Translate trial outcomes into regulatory and scientific narratives aligned with submission standards.
• Review AI-generated clinical insights for accuracy and regulatory alignment.
• Help set standards for how AI systems reason about real-world oncology data.

Skills

Oncology trials

Regulatory submissions

Data analysis

AI evaluation

Async work

Job description

Oncology Clinical Researcher (AI Training)

What if your deep expertise in cancer clinical trials could directly shape how AI understands and reasons about oncology — influencing the tools that researchers, clinicians, and scientists rely on for years to come?

We're looking for Oncology Clinical Researchers to bring real-world rigor to AI-driven research workflows. You'll help ensure that the AI systems being built to support cancer research are grounded in genuine clinical, regulatory, and scientific standards — not approximations.

This is a fully remote, flexible contract role built for oncology professionals who want to do meaningful work on their own schedule.

• Organization: Alignerr
• Type: Hourly Contract
• Location: Remote
• Commitment: 10–40 hours/week

What You'll Do

• Design and evaluate oncology clinical trial protocols, covering study design, patient enrollment frameworks, and regulatory and ethical compliance standards
• Analyze cancer trial data — including safety profiles, efficacy endpoints, and biomarker results — to assess treatment performance and data quality
• Translate trial outcomes into clear regulatory and scientific narratives aligned with FDA/EMA submission standards, publications, and clinical decision-making contexts
• Review and evaluate AI-generated clinical insights for accuracy, scientific validity, and regulatory alignment
• Help set the standard for how frontier AI systems reason about real-world oncology data

Who You Are

• Experienced in designing and managing oncology clinical trials from protocol development through data readout
• Strong background in analyzing oncology clinical data, including endpoints, safety profiles, and biomarkers
• Familiar with regulatory submission standards for agencies such as the FDA or EMA
• Detail-oriented and methodical — you hold AI outputs to the same standards you'd apply in a clinical or regulatory setting
• Comfortable working independently and asynchronously on task-based assignments

Nice to Have

• Prior experience with data annotation, data quality assurance, or AI evaluation workflows
• Background in translational oncology, clinical pharmacology, or medical writing
• Experience preparing or reviewing regulatory submissions (INDs, NDAs, CTDs)
• Familiarity with AI tools or clinical data platforms as an end user

Why Join Us

• Work directly on frontier AI systems transforming how cancer research is conducted and understood
• Influence how AI models reason about real oncology trial data — at a level of depth that actually matters
• Fully remote and flexible — work when and where it suits you
• Freelance autonomy with the structure of meaningful, task-based work
• Collaborate with world-leading AI research teams and labs
• Potential for ongoing work and contract extension as new projects launch